Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

The Relationship of Plasma Visfatin Level and Anorexia in Terminal Cancer Patients

말기암환자의 혈중 Visfatin 농도와 식욕부진의 관계

  • Lee, So Jin (Department of Family Medicine, Korea University College of Medicine) ;
  • Lee, Joon Yong (Department of Family Medicine, Korea University College of Medicine) ;
  • Choi, Youn Seon (Department of Family Medicine, Korea University College of Medicine) ;
  • Lee, June Young (Department of Biostatistics, Korea University College of Medicine)
  • 이소진 (고려대학교 의학대학 가정의학교실) ;
  • 이준용 (고려대학교 의학대학 가정의학교실) ;
  • 최윤선 (고려대학교 의학대학 가정의학교실) ;
  • 이준영 (고려대학교 의학대학 통계학교실)
  • Received : 2013.08.26
  • Accepted : 2014.01.25
  • Published : 2014.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Anorexia is a common symptom in terminal cancer patients. Some data have suggested a role of visfatin in regulating feeding behavior. We studied the relationship of a serum visfatin level and anorexia in cancer patients provided with hospice care. Methods: After informed consent was obtained, 69 cancer patients over 20 years old at a hospice center were enrolled in the study from July 2009 to July 2010. We characterized patients by age, sex, body mass index, primary cancer site, and Eastern Cooperative Oncology Group (ECOG) performance status, etc. Also, blood tests were performed to measure the level of hemoglobin, white blood cell (WBC), C-reactive protein (CRP), total cholesterol, albumin, lymphocyte count, glucose, blood urea nitrogen (BUN), creatinine, tumor necrosis factor-alpha (TNF-${\alpha}$), interukin-6, leptin and visfatin. Results: The mean age of subjects was 65.5 years old, According to univariate analysis, pulse, ECOG performance scale, opioid use and visfatin level were different between the anorexia and non-anorexic group (P<0.05). The median visfatin level was higher in the anorexia group than the good appetite group (P=0.0323). Serum visfatin concentrations were not related with either body mass index or serum leptin or total cholesterol levels, but it was negatively correlated with serum albumin levels (P=0.0198) and lymphocyte counts (P=0.0013). Conclusion: This study did not identify a novel link between visfatin levels and anorexia in cancer patients at a hospice.

목적: 식욕부진은 호스피스 암환자의 흔한 증상이며 여러 문헌에서 먹는 행동(feeding behavior)을 조절하는데 있어 visfatin의 가능성을 제시하고 있다. 본 연구에서는 말기암환자에서 증가한 visfatin 농도가 식욕조절과 영양상태 항상성 조절에 관여할 것이라 가설을 세웠다. 방법: 2009년 7월부터 2010년 7월까지 13개월 동안, 만 20세 이상의 말기암환자 69명을 대상으로 혈장 visfatin 농도를 측정하였다. 나이, 성별, 체질량 지수, 활력 징후, 원발암 부위, 암 치료 경력, 투약상황, ECOG(Eastern Cooperative Oncology Group) 수행지수, 혈색소, 백혈구 수, C-반응성 단백질, 총 콜레스테롤, 알부민, 림프구수, 혈당, 혈액요소질소, 크레아티닌, TNF-${\alpha}$ (tumor necrosis factor-alpha), Interukin-6, 렙틴 등의 혈액검사를 시행하였다. 결과: 대상자의 평균 나이는 65.5세였고 단변량 분석상 맥박, ECOG 수행 지수, opioid 사용여부, visfatin 농도에 따라 식욕부진이 있는 군과 없는 군의 차이를 보였다. Visfatin 농도는 단변량 분석결과 식욕부진과 관련이 있는 것으로 나타났으나(P=0.0323) 식욕부진에 영향을 주는 인자들을 보정한 다중 로지스틱 회귀 분석 결과에서는 통계학적인 관련성이 사라졌다. 영양지표들 중 체질량 지수, 렙틴, 총 콜레스테롤과는 관련이 없었으나 림프구수(P=0.0198) 혈중 albumin 농도(P=0.0013)와 중간 정도의 음의 관련성을 나타냈다. 결론: 호스피스 암환자에서 visfatin과 식욕부진의 관련성은 통계적으로 유의하지 않았다. 향후 기전에 대한 연구와 전향적 연구가 필요할 것으로 생각된다.

Keywords

References

  1. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997;315:1219-22. https://doi.org/10.1136/bmj.315.7117.1219
  2. Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, et al. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 2010; 18:151-7. https://doi.org/10.1007/s00520-009-0639-x
  3. Chow E, Harth T, Hruby G, Finkelstein J, Wu J, Danjoux C. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 2001;13:209-18.
  4. Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 2004;101:1090-8. https://doi.org/10.1002/cncr.20472
  5. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 1993;7:199-204. https://doi.org/10.1177/026921639300700306
  6. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 1992;7:82-6. https://doi.org/10.1016/0885-3924(92)90118-2
  7. Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. ltalian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 1999;17:231-9. https://doi.org/10.1016/S0885-3924(98)00145-6
  8. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004;80:299-307.
  9. Engel JH, Siewerdt F, Jackson R, Akobundu U, Wait C, Sahyoun N. Hardiness, depression, and emotional well-being and their association with appetite in older adults. J Am Geriatr Soc 2011;59:482-7. https://doi.org/10.1111/j.1532-5415.2010.03274.x
  10. Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, et al. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr 2012;22:258-67. https://doi.org/10.1053/j.jrn.2011.07.005
  11. Robertson MD, Henderson RA, Vist GE, Rumsey RD. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord 2004;28:727-33. https://doi.org/10.1038/sj.ijo.0802637
  12. Smiechowska J, Utech A, Taffet G, Hayes T, Marcelli M, Garcia JM. Adipokines in patients with cancer anorexia and cachexia. J Iinvesting Med 2010;58:554-9. https://doi.org/10.2310/JIM.0b013e3181cf91ca
  13. Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 2000;20:93-103. https://doi.org/10.1016/S0885-3924(00)00169-X
  14. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41:64-9. https://doi.org/10.1080/01635581.2001.9680613
  15. Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon MR, et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2006;91:2725-31. https://doi.org/10.1210/jc.2006-0149
  16. Blakemore AI, Meyre D, Delplanque J, Vatin V, Lecoeur C, Marre M, et al. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity (Silver Spring) 2009;17:1549-53. https://doi.org/10.1038/oby.2009.75
  17. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30. https://doi.org/10.1126/science.1097243
  18. Olszanecka-Glinianowicz M, Kocelak P, Janowska J, Skorupa A, Nylec M, Zahorska-Markiewicz B. Plasma visfatin and tumor necrosis factor-alpha (TNF-$\alpha$) levels in metabolic syndrome. Kardiol Pol 2011;69:802-7.
  19. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, et al. Elevated plasma level of visfatin/pre-B cell colony enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-9. https://doi.org/10.1210/jc.2005-1475
  20. Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL, et al. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Invest 2012;42:321-8. https://doi.org/10.1111/j.1365-2362.2011.02586.x
  21. Carrero JJ, Witasp A, Stenvinkel P, Qureshi AR, Heimburger O, Barany P, et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol Dial Transplant 2010;25:901-6. https://doi.org/10.1093/ndt/gfp587
  22. Cline MA, Nandar W, Prall BC, Bowden CN, Denbow DM. Central visfatin causes orexigenic effects in chicks. Behav Brain Res 2008;186:293-7. https://doi.org/10.1016/j.bbr.2007.08.016
  23. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007;85:399-404.
  24. Kovacikova M, Vitkova M, Klimcakova E, Polak J, Hejnova J, Bajzova M, et al. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction. Eur J Clin Invest 2008;38:516-22. https://doi.org/10.1111/j.1365-2362.2008.01964.x
  25. Hallschmid M, Randeva H, Tan BK, Kern W, Lehnert H. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diagetes 2009;58:637-40.
  26. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;279:1709-14. https://doi.org/10.1001/jama.279.21.1709
  27. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7:128-33. https://doi.org/10.1007/s005200050242
  28. Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, et al. Prediction of survival of patients terminally ill with cancer: Results of an ltalian prospective multicentric study. Cancer 1995;75:2613-22. https://doi.org/10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1
  29. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch lntern Med 1988;148:1586-91. https://doi.org/10.1001/archinte.1988.00380070082020
  30. Sungurtekin H, Sungurtekin U, Hanci V, Erdem E. Comparison of two nutrition assessment techniques in hospitalized patients. Nutrition 2004;20:428-32. https://doi.org/10.1016/j.nut.2004.01.006
  31. Zabel R, Ash S, King N, Bauer J. The relationship between subjective appetite sensations, markers of inflammation and appetite in dialysis patients. J Hum Nutr Diet 2009;22:343-50. https://doi.org/10.1111/j.1365-277X.2009.00968.x

Cited by

  1. The Relationship between Opioids Use, Cortisol and DHEAS vol.18, pp.2, 2015, https://doi.org/10.14475/kjhpc.2015.18.2.105